Serum immunoglobulin free light chains are sensitive biomarkers for monitoring disease activity and treatment response in primary Sjögren’s syndrome
暂无分享,去创建一个
A. Vissink | H. Bootsma | B. Hazenberg | M. S. van Ginkel | E. Mossel | J. V. van Nimwegen | R. Moerman | S. Arends | G. Verstappen | F. Kroese | J. Bijzet | M. V. van Ginkel